unknown
Stage
1
Investors
About
VelaVigo is an antibody discovery company incubated by Panacea Venture and founded by Dr. Jing Li. It develops discovery platforms and programs for antibodies, including bi-specific and multi-specific constructs and antibody–drug conjugates across multiple therapeutic areas.
Explore VelaVigo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.